ONE-WAYDated event · through FY2025-H1
Integration of drug discovery support functions through the merger of 新薬リサーチセンター and 安評センター
A standalone reorganization involving the absorption-type merger of 新薬リサーチセンター and 安評センター, integrating the two companies’ technologies and businesses to unify drug discovery support services, consolidate management resources, strengthen sales capabilities and provide services more smoothly.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.
PeriodFY2024-Q3 →Last written FY2025-H1
Directionhelps1 helps · 0 hurts · 0 flat